Clinical Trial Update: Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema [Phase 2]

View source ↗

Summary

Phase 2 trial update for BCX7353 in hereditary angioedema completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• BCX7353

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema (HAE) | Phase 2 | Status: COMPLETED | Results posted: 2021-04-01